Leukemia, Plasma Cell - 19 Studies Found
| Not yet recruiting |
: Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma :
: |
| Completed |
: SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy :
|
| Completed |
: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) :
|
| Completed |
: Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia : Multiple Myeloma and Plasma Cell Neoplasm : 2005-11-22 :
|
| Not yet recruiting |
: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases :
|
| Completed |
: Allo HSCT Using RIC for Hematological Diseases :
|
| Completed |
: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep :
|
| Completed |
: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies :
|
| Active, not recruiting |
: Study of Arry-520 and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma : Myeloma : 2011-06-10 :
|